Array-based Comparative Genomic Hybridization (aCGH) is a microarray-based technology that assists in identification of DNA sequence copy number changes across the genome. Examination of differences in instability phenotype, or pattern of copy number alterations, between cancer subtypes can aid in classification of cancers and lead to better understanding of the underlying cytogenic mechanism. Instability phenotypes are composed of a variety of copy number alteration features including height or magnitude of copy number alteration level, frequency of transition between copy number states such as gain and loss, and total number of altered clones or probes. That is, instability phenotype is multivariate in nature. Current methods of instability phenotype assessment, however, are limited to univariate measures and are therefore limited in both sensitivity and interpretability. In this paper, a novel method of instability assessment is presented that is based on the Engler et al. (2006) pseudolikelhood approach for aCGH data analysis. Through use of a pseudolikelihood ratio test (PLRT), more sensitive assessment of instability phenotype differences between cancer subtypes is possible. Evaluation of the PLRT method is conducted through analysis of a meningioma data set and through simulation studies. Results are shown to be more accurate and more easily interpretable than current measures of instability assessment.
Introduction
Alteration in DNA sequence copy number has been shown to be associated with cancer development and progression. In an attempt to ascertain copy number alterations in tumor samples, array-based comparative genomic hybridization (aCGH) is used to compare genetic material obtained from tumor and reference samples. Both sets of samples are labeled with fluorescent dyes and are hybridized to an array. The resultant set of fluorescence intensity ratios (log 2 scale) can then be analyzed for changes in ratio magnitude. Significant changes in magnitude are presumably indicative of copy number alteration.
To date, many methods of aCGH analysis have been developed for identification of copy number alterations within a single hybridization. Under current approaches, assignment of clones to either altered (gain, loss) segments or nonaltered (no change) segments is conducted. Many authors have utilized a threshold-based approach in which clones with absolute log 2 ratio above a given threshold are classified as altered (e.g., Itzhar et al., 2011; Tap et al., 2011; Tsuji et al., 2010) . Contiguous clones in the same threshold region constitute a single segment. Others have employed assignment mechanisms in which data are first segmented into regions of common mean. Segmentation methods include, but are not limited to, those proposed by Magi et al. (2010) , DeSantis et al. (2009) , Tibshirani and Wang (2008) , Huang et al. (2007) , Picard et al. (2007) , Engler et al. (2006) , Fridlyand et al. (2004) , and Olshen et al. (2004) . Following the initial segmentation analysis, each segment is classified as altered or non-altered either through use of a threshold or through a method of segment combination (e.g., FastCall , CGHcall (van de Wiel et al., 2007) , MergeLevels (Willenbrock and Fridlyand, 2005) , GLADmerge (Hupe et al., 2004) ).
It is often of interest, however, to not only identify regions of alteration for a given hybridization, but to also make comparisons across hybridization groups. Various authors have proposed methods for identification of regions of common change across hybridization groups (see Walter et al., 2011; Baladandayuthapani et al., 2010; Lai et al., 2007; Shah et al., 2007; Diskin et al., 2006; Lipson et al., 2006; Rouveirol et al., 2006) . A separate objective of interest is the examination of the overall patterns of alteration across hybridization groups. Such assessment of the DNA sequence copy number loss and gain "phenotype", or pattern of gain and loss, across hybridization groups can be used both to accurately subtype cancers and to understand the underlying cytogenic mechanisms. In a current study of meningioma tumors, for example, identification of differences in genetic instability patterns between different pathological grades of meningioma is of interest.
In the past several years, there has emerged a small body of literature in which simple measures of aCGH-based genetic instability pattern assessment have been developed and used (e.g., Vilardell et al., 2008; Fridlyand et al., 2006; Herzog et al., 2006; Bernardini et al., 2005; Blaveri et al., 2005) . Current metrics however, often fail to distinguish between different types of genetic instability and are difficult to interpret. Moreover, many current comparisons are made as a second stage analysis following employment of ad hoc copy number loss and gain identification methods.
In this paper, a novel method of aCGH-based instability assessment is presented. The method is based on a pseudolikelihood ratio test (PLRT) and utilizes the aCGH modeling approach presented by Engler et al. (2006) . An evaluation of the method is presented through comparison of instability features between meningioma cancer subtypes and through simulation studies. Results are compared with those obtained from existing instability metrics. The PLRT method is shown to be more sensitive with regard to distinguishing between different instability types.
Genetic Instability
Cancer development and progression is a complex process that is influenced by a variety of environmental and genetic factors. While understanding of the entire etiologic process is not complete, it is generally accepted that genetic instability, introduced through defects in the cytogenic mechanism, leads to the unregulated cell growth that characterizes tumorigenesis (Michor et al., 2004) . Such defects may take a variety of forms. For one, genetic alteration can result in the formation of one or more oncogenes. Oncogenes are genes involved in the process of proliferation that when mutated or expressed at abnormally high levels lead to uncontrolled cell division and creation. Alternatively, gene mutation might lead to a change in the actual protein product of a gene. If such a change led to the constant activation of the product, even in the absence of positive signals, an increase in cell division and replication might occur. Genetic alteration might also lead to the inactivation of tumor suppressor genes. Tumor suppressor genes are genes whose product suppresses proliferation. Inactivation of one or more of these genes might lead to unregulated cell growth. A similar result might be observed if gene mutation leads to an insensitivity to antigrowth signals. The failure of apoptosis, necessary for cell population regulation, is a third possible result of gene mutation.
These cytogenic defects along with others (see Hanahan and Weinb erg, 2000) can be introduced by a variety of genetic events such as whole chromosome loss, segment deletion, segment amplification, translocations, and inver-sions. There are, in turn, a variety of tools such as FISH, M-FISH, expression analysis, SKY, microsatellite analysis, DNA sequencing, and aCGH that are used to identify occurrences of these varied events. Ideally, results from these methods would be used to ascertain locations of cancer-susceptibility genes along with the specific mutations that lead to unregulated cell growth.
aCGH-Based Genetic Instability Assessment
Analysis of aCGH-based instability plays an important role in the attempt to understand the events involved in cancer progression. Links between cytogenic mechanism defect and three basic patterns of copy number alteration have been established (see Navin et al., 2010; Fridlyand et al., 2006; Davies et al., 2005; Pinkel and Albertson, 2005; Rajagopalan et al., 2003; Snijders et al., 2003; Nowak et al., 2002) .
First, the total amount of alteration is informative regarding specific cytogenic mechanisms underlying the cancer; cancer progression is often characterized by an increase in the total amount of copy number alteration.
Second, the frequency of transition between states such as copy number gain, loss, and no-change (i.e., no gain or loss) may be associated with cancer etiology. For example, whole chromosome loss, or aneuploidy, is often due to chromosomal instability (CIN). In contrast, tumors with mismatch repair (MMR) deficiencies exhibit few chromosome-wide alterations; alterations in these tumors are typically narrow in scope. Changes in the frequency of transition between states may also reflect differences in cancer stage; a higher frequency of transition is often associated with cancer progression. For example, two meningioma tumors from a current study are shown in Figure 1 . The tumors, taken from two distinct clinical subtypes (benign and malignant), differ with respect to the frequency of alteration.
Third, the copy number alteration level (i.e., mean log 2 ratio level) may also reflect cancer stage. In Figure 2 , two meningioma tumors from separate subtypes (benign and atypical) with varying copy number levels are shown.
Copy number phenotype is then comprised of these three patterns of alteration. By quantifying and comparing differences in copy number phenotype across cancer subtypes, improvements in the understanding of cancer etiology might be made.
Current Measures of aCGH-Based Instability
Current measures of aCGH-based instability assessment are dependent upon a data preprocessing step in which assignment of clones to either altered (gain, loss) segments or non-altered (no change) segments is first conducted (see Section 1). Assessment of aCGH-based instability is then assessed based on the segmentation results. To date, such assessment has been conducted through the use of univariate segment-based metrics in which a summary number is calculated for each hybridization and comparisions are made across tumor groups or subtypes.
Primarily, these metrics have been based upon the total number of altered clones (i.e., the sum of altered segment lengths) per tumor. In some recent studies, differences (across cancer subtypes) in the average number of alterations per hybridization were merely reported and statistical significance was not assessed (see, e.g., Itzhar et al., 2011; Tap et al., 2011; Rousseau et al., 2010; Liu et al., 2009; Carvalho et al., 2007; Bernardini et al., 2005) . Other authors have made comparisons based upon the total number of altered clones per tumor were made utilizing tests of statistical significance (see, e.g., Buffart et al., 2011; Tsuji et al., 2010; Hsu et al., 2008; Natrajan et al., 2007; O'Regan et al., 2006; Wilting et al., 2006; Jones et al., 2005) .
Additional univariate segmentation-based metrics have also been employed. Herzog et al. (2006) and Blaveri et al. (2005) , for example, examined differences in the number of whole chromosome altered segments per tumor across cancer subtypes. Blaveri et al. (2005) also employed both the average number of segments (per tumor) and the average number of chromosomes (per tumor) containing at least two segments as measures of instability.
Alternative Segmentation-Based Measures of Instability
Notably, no current segmentation-based measure incorporates the magnitude or height of alteration level. As discussed, however, alteration height differences are an important component of instability assessment. Several potentially useful measures that incorporate segment height are possible. First, the total absolute area under the "curve" might be used where the area created by each segment is its length multiplied by its absolute mean magnitude. The metric is calculated as the sum of the individual areas. The average over all individual i in group g is then
where h s and w s denote the magnitude and length of segment s, respectively. A second possible metric that incorporates segment height makes specific use of the vertical distance between adjacent segments at each breakpoint. The distance metric is calculated as the sum of these distances across all breakpoints in a given hybridization:
Both the area and the distance metrics provide a combined measure of the magnitude and the number of alterations. That is, the measures would provide a higher value for a tumor with a given number of large-magnitude alterations than they would for a tumor with the same number of small-magnitude alterations. Performance of these two metrics is evaluated in Sections 3.1 and 3.2.
Limitations of Current Methods
Current methods of genetic instability assessment have several limitations. First, they often fail to distinguish between different types of genetic instability. For example, using the sum of altered segment lengths (i.e., the total number of altered clones) a set of tumors primarily consisting of a few whole chromosome alterations would not be distinguished from a set consisting of a larger number of small alterations when the total number of average alterations per tumor in both sets is similar. Similarly, no distinction is made using this metric when the difference between sets entails a difference in magnitude or height of altered segments.
Second, results obtained from current metrics are sometimes difficult to interpret. This is due to the fact that while instability is characterized by several distinct features (e.g., magnitude of copy number alteration level, total amount of alteration, frequency of transition between states such as gain and loss), the metrics described in Sections 1.3 and 1.4 are all univariate. Because differences in instability phenotype may be comprised of differences in any combination of these features, interpretation of univariate metrics can be difficult; it is often not clear which combination of feature differences results in an identified difference (or lack of identified difference) between cancer subtypes. Hence, use of a single univariate is limited in this setting.
A third limitation of some current methods is that they require a second stage of analysis following ad hoc methods of DNA sequence copy number alteration identification. For example, most methods of overall instability assessment are based on the initial identification of altered segments through the use of author-selected thresholds (Itzhar et al., 2011; Tap et al., 2011; Rousseau et al., 2010; Tsuji et al., 2010; Liu et al., 2009; Hsu et al., 2008; O'Regan et al., 2006; Jones et al., 2005) . Alternatively, Fridlyand et al. (2006) used the MergeLevels segment combination procedure as a foundation for genetic instability assessment. The MergeLevels approach does not require ad hoc selection of a threshold. However, the MergeLevels approach may be limited in its ability to detect small regions of alteration (see Engler et al., 2006) and may hence lead to insensitive measures of instability.
2 Methods: A Model-Based Method of Instability Assessment
Pseudolikelihood Approach for aCGH Classification
Engler et al. (2006) proposed a likelihood-based aCGH classification method that offers a formal modeling framework upon which a method for instability assessment can be developed. The approach is based on a three-state Gaussian mixture model (for loss, no-change, and gain events), with a hidden Markov dependence structure, and with random effects to allow for both intertumoral and intratumoral clonal variation. For computational ease, estimation of model parameters and of posterior event probabilities is based on a pseudolikelihood function (see Arnold and Strauss, 1991) in which dependencies within each triplet of data are modeled and the likelihood contribution of each triplet are multiplied together. The method provides posterior probabilities of gain, loss, and no change, supplying quantitative evidence of alteration events. Through data analysis and simulation studies, Engler et al. (2006) showed that the method more accurately classifies small regions of alterations than segmentation-based methods. The authors also found that the method has greater accuracy when intratumoral clonal variation is present. Under the proposed model, the contribution of a given data triplet on the m th chromosome and i th hybridization is
where C contains the set of unobserved states (C j−1 , C j , C j+1 ) for the data triplet x j−1 , x j , and x j+1 , where the random vector γcontains the random means for loss (γ L ), no-change (γ 0 ), and gain (γ G ). For identifiability, it is assumed that the random effects, γ L ,γ 0 , and γ G , follow truncated normal distributions with means µ L , µ 0 , and µ G , such that γ L < −ε <γ 0 < ε <γ G . It is also assumed that the unobserved states C follow a one-step Markov process:
where t c,c ′ ∈ T denotes the probability of transitioning from state C ′ to state C and π c denotes the marginal probability of state C.
The parameter vector Θhence contains the parameters underlying both the distributions of the random effects (means and variances) and the dependence structure of the C's (marginal and transition probabilities). Parameter estimates for Θcan be obtained through iterative optimization techniques.
Several elements of this modeling approach are particularly well-suited to instability assessment. For one, an important component of instability phenotype is the magnitude or height of alteration levels. Through estimation of the underlying state mean parameters, µ L , µ 0 , and µ G , the approach provides such information. Second, both the overall amount of alteration and the frequency of transition between states of loss, no-change, and gain are also important components of the instability pattern. By incorporating the Markov dependence structure, the model quantifies these features through the marginal state and transition probabilities, π and T, respectively. 
Pseudolikelihood Ratio Test (PLRT)
As described in Section 1.5, univariate measures provide an incomplete summary of differences in instability phenotype. A test that globally assesses differences in copy number segment level, frequency of alteration, and total amount of alteration is of interest. Because various parameters of the pseudolikelihood approach correspond to these features of interest, the approach can be utilized in comparisons of differences between tumors sets. Namely, through formal evaluation of differences in state means, marginal probabilities, and transition probabilities, differences in copy number phenotype across tumor sets can be assessed. For example, under one possible (and seemingly natural) null hypothesis, different cancer subtypes could be represented by a single set of mean parameters, marginal probabilities, and transition probabilities. Given this null, a variety of alternative hypotheses are possible. If it were of interest to test for differences in the magnitude of transition events (i.e., heights of altered segments) between two groups, the mean parameters would be allowed to vary between two groups. Alternatively, the marginal and transition probabilities would be allowed to vary between two groups if it were of interest to test whether the total amount of alteration and frequency of transition between states differed between the two groups. Under the global alternative hypothesis of any difference between groups, the two mean parameters along with the marginal and transition probabilities would be allowed to vary between groups.
To fix ideas, let (x 1 , . . . , x N ) represent vectors of log 2 ratios from all N hybridizations. Let S be the set of all possible unique tripletwise indicator vectors s for a hybridization with J clones; each s ∈ S is of length J and consists of three consecutive 1's, and 0's for the remaining J−3 entries. Finally, let x (s) i be the subvector of x i that corresponds to the elements of s equal to 1. The log pseudolikelihood then can be represented as
where f s is the likelihood contribution (3) for each triplet s, C s is the vector consisting of the true underlying states for the triplet, and Θis the vector of model parameters including the state mean parameters and the marginal and transition probabilities. Let the complete parameter vector be represented as Θ= (α,δ), where δ=δ 0 is the subvector of interest and where αis a nuisance parameter vector.
For example, one test of interest entails examining whether the means of DNA sequence copy number gain and loss for one subgroup differ from the means of gain and loss of a second subgroup. Let δ= (δ G ,δ L ) and let α= (µ G , µ L , v), where v represents the vector containing the remaining model parameters. Under H 0 , µ G and µ L represent the mean of DNA copy number gain and loss, respectively, for the entire set of hybridizations. Under the alternative hypothesis, H A , µ E is the mean of event E, E = G, L, in group 1 and (µ E +δ E ) is the mean of event E in group 2. Under H 0 ,δ= 0.
A formal comparison of H 0 and H A can then be conducted using the pseudolikelihood ratio test statistic.
where the function pl(.) is defined in (4),˜Θis the vector of maximum pseudolikelihood estimates, and where˜α(δ 0 ) is the vector of maximum pseudolikelihood estimates for αunder H 0 . Of interest, then, is the asymptotic distribution of (5) under H 0 . Let
Also, define ν r as the eigenvalues of (J R ) −1 Σ R , where J R is the R×R submatrix of the inverse of J corresponding to αand where Σ R is the R × R submatrix of Σ= J −1 KJ −1 . Then, it can be shown that the asymptotic distribution of (5) is the weighted sum of independent χ 2 1 (see Geys et al., 1999) :
When needed, estimation of the weights ν r can be based on numerical approximations of the first and second derivatives of the pseudolikelihood function. Following estimation of the weights, testing can be conducted by comparing the observed value of (5) to the null distribution (6). When the complexity of (6) prohibits the calculation of the quantile of interest, quantile estimation can be conducted through use of simulation methods (e.g., Metropolis-Hastings) in which a sufficiently large number of draws is obtained from the null distribution. Performance of the pseudolikelihood ratio test (PLRT) is evaluated in Sections 3.1 and 3.2. Use of alternative formal testing procedures is also possible. Geys et al. (1999) , for example, proposed use of pseudolikelihood-based score tests and Wald tests. However, through simulation studies, the authors found that the pseudoscore test and Wald test had lower power than their likelihood-based counterparts and suggested use of the pseudolikelihood ratio test. Formal subgroup comparison is also possible through use of a permutation test in which the group labels are randomly permuted among hybridizations. For each set of label assignments, the pseudolikelihood ratio test statistic, G 2 , is computed. The value of G 2 under the true hybridization assignment is then compared to its permutation distribution and a p-value is calculated. Of note, the permutation test can be useful in examining the effect of model assumptions. Assessment of PLRT model assumptions using a small permutation test is described in Section 3.1. However, because aCGH data sets are typically quite large, this approach is not practical because of its computational burden.
Software
Analyses were performed using the R software package (http://www.r-project.org). The R implementation of the pseudolikelihood ratio tests presented in this paper is available upon request from the authors.
Results

Meningioma Data
Meningiomas are a common type of intracranial tumor. Previous studies have established that patients with neurofibromatosis type 2 (NF2) are particularly susceptible to tumor development and progression. However, meningiomas also occur sporadically in individuals without NF2. In such cases, the genetic etiology is generally unknown. A current study analyzes genomic DNA from a cohort of sporadic solitary meningiomas using cDNA microarray chips. Normalization of samples was based upon dye swap experiments in which the mean and standard deviation of the signal for each target clone were obtained. A total of 72 samples were previously classified as benign (n = 34), atypical (n = 25), or malignant (n = 13). It is of interest to test for differences in genetic instability between pathological grades. Several segmentation-based instability metrics were calculated to assess differences in instability type between the three cancer subtype groups. First, for each hybridization, the sum of altered segment lengths (SSL) was calculated using a specified threshold w. Clones with an absolute magnitude greater than threshold w were categorized as alterations (i.e., gains or losses). The threshold value w = 0.25 was identified by the study authors as one appropriate for this particular data set. To check sensitivity to threshold choice in instability assessment, values of 0.20 and 0.30 were also used in separate analyses. An additional analysis was conducted through use of the weighted median absolute deviation (MMAD) (see Korkola et al., 2008) in which a nonparametric estimate,σ, of the standard deviation for each hybridization is obtained using segmentation results. For this analysis, all clones belonging to segments with means above w = 2σ or below w = −2σ were categorized as gains or losses, respectively.
Second, the CBS approach (Olshen et al., 2004) was used as the basis for the two segmentation metrics described in Section 1.4. Both the "area" metric and the "distance" metric were calculated for each hybridization using the combined CBS segments of the MergeLevels (Willenbrock and Fridlyand, 2005) approach.
For each of the above metrics, a Wilcoxon rank-sum test was used to test for significant differences between groups. Table 1 contains the Wilcoxon ranksum test results for each of the two-group comparisons using each of the instability metrics. The group comparisons are benign vs. atypical (B-A), atypical vs. malignant (A-M), and benign vs. malignant (B-M). All methods of segmentation-based instability assessment identify a significant difference (at the Bonferroni-corrected level of 0.017) between the two most clinically distinct subtypes of benign and malignant. Additionally, a number of methods also identify a significant difference in amount of alteration between the benign and atypical subtypes. In the comparison between the atypical and malignant subtypes, no metric detects a difference between the two groups. Even if attention is restricted to the comparison (benign and malignant) where there is general agreement across metrics, it is difficult to assess the nature of the instability phenotype differences between the two groups in terms of biologically meaningful parameters. That is, it is unclear whether the differences are due to variations in the total number of alterations, in the frequency of transition between states, or in the magnitude of alteration events. Additionally, the wide range of p-values across metrics for the remaining comparisons suggests additional complexity in instability differences that is not easily explained by univariate measures and that might be more effectively modeled through use of a more robust approach.
Comparisons between groups were also made using the pseudolikelihood ratio tests (PLRTs). For each two-group comparison, four PLRTs were conducted. Results are displayed in Table 2 . First, differences in magnitude of alteration levels were assessed using means-tests, which test the null hypothesis that the mean levels of gain and loss are the same across both groups. Second, differences in frequencies of changes between states were assessed using transition-probability-tests, which test the null hypothesis that the transition probabilities are the same across both groups. Third, differences in overall amount of gain and loss events were assessed using state-probability-tests, which test the null hypothesis that the marginal probabilities of alteration do not vary across groups. Global-tests were also conducted, which consisted of joint comparisons of means, transition probabilities, and state probabilities.
The benign and malignant groups differ both in the magnitude of alteration levels (p=0.0092) and in the overall amount of gain and loss (p=0.0133). The two groups do not differ with regard to frequency of transition between event states (p=0.2159). The two groups were also found to differ marginally under the global test, in which state means, transition probabilities, and marginal state probabilities were allowed to vary across groups. Hence, the benign and malignant groups differ primarily in magnitude of alteration levels and in the overall amount of gain and loss. Notably, these results are more informative than those provided by the segmentation-based metrics in which assessment of specific instability phenotype differences is not feasible.
The benign and atypical groups differ significantly in the magnitude of alteration levels (p=0.0005) and marginally in the overall amount of gain and loss (p=0.0377). They were also found to differ marginally under the global test (p=0.0313). Thus, as in the benign-malignant comparison, the benign and atypical groups differ primarily in magnitude of alteration levels and in the overall amount of gain and loss. Again, the difference in descriptive power between the PLRT results and the segmentation-based results is notable.
Simulations
Simulation studies were conducted to compare the performance of various instability metrics under several data scenarios. For an initial set of scenarios, simulated data were generated using a Markov dependence structure in which overall alteration, frequency of alteration, and average segment levels were specified. Simulated log 2 ratios were distributed normally about the segment levels. For the first simulation study under this data generation approach, frequency of alteration varied across groups and segment levels and overall alteration did not. For this simulation, 200 data sets were generated, consisting of two groups of n = 8 hybridizations per group with 500 data points per hybridization. Results of this simulation study are presented in Tables 3 and  4 under the heading "Scenario 1". For the second simulation study under this data generation approach, segment levels and frequency of alteration varied between the two groups and the overall amount of gain and loss did not. For this study, 200 simulated data sets were generated, each consisting of two groups of n = 15 hybridizations per group with 1000 data points each. Results of this second scenario are provided in Tables 3 and 4 under the heading "Scenario 2"
In Scenario 1, the overall amount of alteration (i.e., the total number of clones categorized as alterations) and the mean levels of alteration do not vary between groups. The area metric and the threshold-based sum of segment lengths (SSL) will, on average, fail to distinguish between groups when the sole difference is in the frequency of transition between event states. Alternatively, the distance metric will be able to distinguish between groups in this scenario since an increase in the frequency of transition between states (holding all else constant) will result in more segments and a greater sum distance between segments. The power estimates for these metrics at α= 0.05 are listed in Table 3 and conform to these expectations. The low power (0.065) of the SSL metric is due to the fact that the metric is threshold based and does not detect differences between groups unless the overall amount of transition varies. The Type-I error for the PLRT means-test is 0.050 (Table 4) ; under Scenario 1 no true difference exists between the state means of the two groups. For the transition-probability-test, high power (0.855) is observed in this data scenario. Since the only difference between the two groups is in the frequency of transition between events, this is to be expected. The global-test has a lower power (0.325) than the transition-probability-test in this scenario. This is due to the fact that the average segment levels and frequency of alteration do not vary between the two groups. Hence, the estimates of the parameters corresponding to these data features (state means and transition probabilities) do not vary greatly across groups. As in the data analysis, the PLRT test results provide more information as to the specific type of instability differences between the two groups than do the univariate metric based tests.
For Scenario 2, all three segmentation-based metrics have low power. The area metric is more powerful (0.270) than the distance metric (0.045); for this scenario, the differences in segment level and frequency of alteration are such that, on average, the area metric identifies a difference between groups but the distance metric does not. The SSL test again has low power (0.085) in this case due to the fact that the overall amount of alteration does not vary between the two groups.
The PLRT means-test and global-test have the highest power (1.000) of the three PLRT tests. The lower power of the transition-probability-test is seemingly due to model misspecification; under the alternative hypothesis for this test the state means are constrained to be equal while the transition probabilities are allowed to vary. Again, results of the PLRTs are easily interpretable and provide a greater amount of information with regard to instability type differences between subgroups.
As noted, data for this initial set of simulations were generated through use of a Markovian model. It was also of interest to assess performance of the PLRT tests under an alternative data generation mechanism. Moreover, assessment of PLRT test power over various scenarios was also of interest. Hence, a second set of simulations was conducted in which a modification of the data generation method of Willenbrock and Fridlyand (2005) was employed to assess power for the PLRT global-test.
The Willenbrock and Fridlyand approach requires the use of actual segmented aCGH data. For the current analyses, the meningioma aCGH data described in Section 3.1 were utilized. Segmentation was conducted through use of circular binary segmentation (CBS) (Olshen et al., 2004) . Classification (i.e., assignment as loss, no-change, or gain) of the resultant segments was conducted through use of the weighted median absolute deviation (MMAD) as outlined by Korkola et al., 2008. Of note, the Willenbrock and Fridlyand approach is designed for the generation of aCGH data samples from a homogeneous population. The assessment of PLRT test power, however, requires comparisons between distinct subgroups. Hence, to facilitate this assessment, a modification of the proposed approach was adopted. Willenbrock and Fridlyand initiate segment generation by sampling from the empirical distributions of segment lengths and segment magnitudes for gains, no-change, and loss. For the current analyses, two separate sets of pseudo-empirical distributions were utilized to allow for the generation of two disparate hybridization subgroups. Each distribution was based roughly on the segment length and magnitude distributions of the meningioma data. However, to allow for the assessment of PLRT test power with respect to difference in mean magnitudes, the difference between the segment magnitude means (of the distributions underlying data generation for each of the two groups) was specified. Likewise, to allow for the assessment of PLRT test power with respect to difference in alteration frequency, the difference between the segment length means (of the distributions underlying data generation for each of the two groups) was specified. Aside from this alteration, segment generation and the addition of noise for a given subject was conducted as outlined by Willenbrock and Fridlyand. Power calculations based on this second set of simulations for the PLRTglobal test are presented in Table 5 . Each cell in Table 5 contains the calculated power for a specified difference in segment mean lengths and segment mean magnitudes. For example, the upper-left cell contains the calculated power (0.39) of the PLRT-global test under a mean difference of 0.003 in segment magnitude differences (between groups) and a mean difference of 200 markers in segment length differences (between groups).
Discussion
To date, all methods of instability assessment are based on univariate measures. However, instability phenotypes are multidimensional and are comprised of several features such as magnitude of copy number alteration level, total amount of alteration, and frequency of transition between states such as gain and loss. Differences in instability phenotype may be due to differences in any combination of these features. Because of this potential complexity, interpretation of univariate metrics is difficult; it is often not clear which combination of feature differences results in an identified difference (or lack of identified difference) between cancer subtypes. Hence, use of a single univariate metric is limited in this setting.
The PLRT, alternatively, provides clear assessment of instability differences. Through this approach, differences in magnitude of copy number alteration level, total amount of alteration, and frequency of transition between states can be assessed directly through tests involving mean parameters, marginal state probabilities, and transition probabilities, respectively. Tests for differences in specific combinations of these instability phenotype features can likewise be conducted.
It may be noted that under this framework, there are a large number of potential hypotheses of interest. Indeed, one of the strengths of the proposed approach is its adaptability to varying hypotheses of interest. Of course, the number of potential hypotheses might also be overwhelming, e.g., it is conceivable that one might test differences between any distinct subset of model parameters. In practice, utilization of the four tests implemented in Section 3.1 might typically be sufficient to characterize aCGH-based differences between subgroups that may be biologically relevant (see Section 1.2). Further investigation of additional potential tests, however, may be warranted.
